Cardiogenic embolism is increasingly appreciated as an important and preventable cause of stroke. Several potential sources of embolism have been identified with the advent of transoesophageal echocardiography. Their role as independent risk factors for stroke and management implications based on recent evidence, along with characterization of schemes for antithrombotic management of patients with atrial fibrillation are reviewed.